Thromboprophylaxis in multiple myeloma: is the evidence there?
作者信息
Kristinsson Sigurdur Yngvi, Landgren Ola
出版信息
Expert Rev Anticancer Ther. 2012 Mar;12(3):291-4. doi: 10.1586/era.11.214.
Abstract
摘要
相似文献
1
Thromboprophylaxis in multiple myeloma: is the evidence there?
Expert Rev Anticancer Ther. 2012 Mar;12(3):291-4. doi: 10.1586/era.11.214.
2
Thalidomide thromboprophylaxis in multiple myeloma: a review of current evidence.
Asia Pac J Clin Oncol. 2012 Dec;8(4):319-24. doi: 10.1111/j.1743-7563.2011.01511.x. Epub 2012 Apr 23.
3
[Thromboprophylaxis in patients with multiply myeloma who receives chemotherapy with thalidomide].
Lik Sprava. 2011 Apr-Jun(3-4):44-50.
4
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
J Clin Oncol. 2011 Mar 10;29(8):986-93. doi: 10.1200/JCO.2010.31.6844. Epub 2011 Jan 31.
5
A review of the venous thrombotic issues associated with multiple myeloma.
Expert Rev Hematol. 2016 Jul;9(7):695-706. doi: 10.1080/17474086.2016.1194750. Epub 2016 Jun 8.
6
A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of thromboprophylaxis with aspirin and warfarin.
Thromb Res. 2013 Feb;131(2):140-4. doi: 10.1016/j.thromres.2012.11.014. Epub 2012 Dec 8.
7
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Cochrane Database Syst Rev. 2020 Dec 18;12(12):CD008500. doi: 10.1002/14651858.CD008500.pub5.
8
The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma.
Mayo Clin Proc. 2005 Dec;80(12):1568-74. doi: 10.4065/80.12.1568.
9
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.
Blood. 2012 Jan 26;119(4):933-9; quiz 1093. doi: 10.1182/blood-2011-03-344333. Epub 2011 Aug 11.
10
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Cochrane Database Syst Rev. 2016 Dec 1;12(12):CD008500. doi: 10.1002/14651858.CD008500.pub4.
引用本文的文献
1
Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials.
Ther Adv Med Oncol. 2024 Sep 2;16:17588359241275387. doi: 10.1177/17588359241275387. eCollection 2024.
2
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma.
Thromb J. 2023 Oct 4;21(1):105. doi: 10.1186/s12959-023-00534-y.
3
Comparison of three risk assessment models for thromboembolism in multiple myeloma patients receiving immunomodulators: a Brazilian historical cohort.
J Thromb Thrombolysis. 2023 Jul;56(1):147-155. doi: 10.1007/s11239-023-02817-7. Epub 2023 May 3.
本文引用的文献
1
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines.
Ann Oncol. 2011 Sep;22 Suppl 6:vi85-92. doi: 10.1093/annonc/mdr392.
2
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.
Blood. 2012 Jan 26;119(4):933-9; quiz 1093. doi: 10.1182/blood-2011-03-344333. Epub 2011 Aug 11.
3
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
J Clin Oncol. 2011 Mar 10;29(8):986-93. doi: 10.1200/JCO.2010.31.6844. Epub 2011 Jan 31.
4
Thrombosis in multiple myeloma.
Hematology Am Soc Hematol Educ Program. 2010;2010:437-44. doi: 10.1182/asheducation-2010.1.437.
5
New aspects on treatment modalities for thromboembolic episodes.
J Intern Med. 2010 Aug;268(2):109-19. doi: 10.1111/j.1365-2796.2010.02242.x. Epub 2010 Apr 20.
6
Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines.
Thromb Res. 2010 Apr;125 Suppl 2:S120-7. doi: 10.1016/S0049-3848(10)70029-3.
7
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.
Blood. 2010 Jun 17;115(24):4991-8. doi: 10.1182/blood-2009-11-252072. Epub 2010 Mar 18.
8
American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty.
J Bone Joint Surg Am. 2009 Jul;91(7):1756-7. doi: 10.2106/JBJS.I.00511.
9
Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone.
Ann Hematol. 2009 Jan;88(1):67-71. doi: 10.1007/s00277-008-0561-1. Epub 2008 Jul 31.
10
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest. 2008 Jun;133(6 Suppl):381S-453S. doi: 10.1378/chest.08-0656.
Zotero 插件